<DOC>
	<DOCNO>NCT02267200</DOCNO>
	<brief_summary>The purpose study analyse sensitivity specificity circulate endothelial cell predict irreversible pulmonary arterial hypertension associate congenital heart disease .</brief_summary>
	<brief_title>The Screening Analysis Plasma Biomarkers Irreversible PAH-CHD</brief_title>
	<detailed_description>predict recruit 100 patient pulmonary arterial hypertension ( PAH ) associate CHD，under commitment child 's parents，take 3-4ml central venous blood corrective surgery，then calculate number circulate endothelial cell flow cytometer AND detect expression micro RNAs screen biomarker，through 6 month follow-up , separate reversible irreversible PAH , carry statistic .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<criteria>Only patient systolic PAP ( sPAP ) &gt; 65mmHg surgery include . Patients trisomy 21 ( Down syndrome ) include</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>biomarkers，pulmonary arterial hypertension</keyword>
</DOC>